ArticleTherapeutic advances in chronic disease2022

Effectiveness and safety of low-dose interferon alpha-2a treatment in Behçet's Syndrome with refractory vascular or neurological involvement: a case series.

Luxi Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.